American Chemical Society--233rd National Meeting. Novel compounds targeting metabolic syndrome. 25-29 March 2007, Chicago, IL, USA.
Turner
Ben
B
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. ben.turner@thomson.com
Bright
Jonathan
J
D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase / Q000037:antagonists & inhibitors; D000818:Animals; D016503:Drug Delivery Systems; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology; D006801:Humans; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009097:Multienzyme Complexes / Q000187:drug effects / Q000378:metabolism; D047493:PPAR alpha / Q000187:drug effects / Q000378:metabolism; D047495:PPAR gamma / Q000187:drug effects / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000187:drug effects / Q000378:metabolism; D013230:Stearoyl-CoA Desaturase / Q000037:antagonists & inhibitors
D015507:Drugs, Investigational; D004791:Enzyme Inhibitors; D009097:Multienzyme Complexes; D047493:PPAR alpha; D047495:PPAR gamma; D013230:Stearoyl-CoA Desaturase; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase